Monitored Implementation of COVID-19 Rapid Antigen Screening at Taxi Ranks in Johannesburg, South Africa.

COVID-19 SARS-CoV-2 South Africa antigen community-based testing differentiated care digital rapid taxi rank testing

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
03 Feb 2022
Historique:
received: 30 12 2021
revised: 23 01 2022
accepted: 28 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Digital tools can support community-based decentralized testing initiatives to broaden access to COVID-19 diagnosis, especially in high-transmission settings. This operational study investigated the use of antigen-detecting rapid diagnostic tests (Ag-RDTs) for COVID-19 combined with an end-to-end digital health solution, in three taxi ranks in Johannesburg, South Africa. Members of the public were eligible if they were aged ≥18 years, could read, and had a cellphone. Over 15,000 participants, enrolled between June and September 2021, were screened for COVID-19 risk factors. A digital risk questionnaire identified 2061 (13%) participants as moderate risk and 2987 (19%) as high risk, based on symptoms and/or recent exposure to a known case. Of this group referred for testing, 3997 (79%) received Ag-RDTs, with positivity rates of 5.1% in the "high-risk" group and 0.8% in the "moderate-risk" group. A subset of 569 randomly selected participants received additional PCR testing. Sensitivity of the Ag-RDT in this setting was 40% (95% CI: 30.3%, 50.3%); most false negatives had high cycle threshold values (>25), hence low viral loads. Over 80% of participants who tested positive completed a 2-week phone-based follow-up questionnaire. Overall, the digital tool combined with Ag-RDTs enhanced community-based decentralized COVID-19 testing service delivery, reporting and follow-up.

Identifiants

pubmed: 35204493
pii: diagnostics12020402
doi: 10.3390/diagnostics12020402
pmc: PMC8871379
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : FIND and Ezintsha
ID : NL-COVI01

Références

Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705
pubmed: 33760236
PLoS Med. 2021 Nov 24;18(11):e1003867
pubmed: 34818336
PLoS Med. 2021 Aug 12;18(8):e1003735
pubmed: 34383750
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
Lancet Glob Health. 2021 Sep;9(9):e1216-e1225
pubmed: 34252381
JMIR Mhealth Uhealth. 2020 Apr 21;8(4):e17246
pubmed: 32314977
J Clin Tuberc Other Mycobact Dis. 2019 Jun 19;16:100110
pubmed: 31720434
Front Pediatr. 2021 Mar 16;9:645577
pubmed: 33796490
JMIR Mhealth Uhealth. 2020 Jan 15;8(1):e13133
pubmed: 31939743
Epidemiol Infect. 2020 Sep 11;148:e208
pubmed: 32912370
EClinicalMedicine. 2021 Jun;36:100924
pubmed: 34101770
Malar J. 2019 Feb 21;18(1):45
pubmed: 30791909
Nat Med. 2020 Aug;26(8):1183-1192
pubmed: 32770165
PLoS One. 2021 Jul 16;16(7):e0253927
pubmed: 34270582
MMWR Morb Mortal Wkly Rep. 2021 Jan 01;69(5152):1642-1647
pubmed: 33382679
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1809-1814
pubmed: 32956925
EClinicalMedicine. 2021 Jan;31:100677
pubmed: 33521610
Lancet Infect Dis. 2021 Oct;21(10):1365-1372
pubmed: 34051886
Reprod Health. 2020 Jul 31;17(1):116
pubmed: 32736561
Am J Epidemiol. 2013 Mar 15;177(6):556-61
pubmed: 23423215

Auteurs

Mohammed Majam (M)

Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.

Vanessa Msolomba (V)

Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.

François Venter (F)

Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.

Lesley Erica Scott (LE)

Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg 2193, South Africa.

Trish Kahamba (T)

Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg 2193, South Africa.

Wendy Susan Stevens (WS)

Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg 2193, South Africa.
The National Priority Program of the National Health Laboratory Service, Johannesburg 2193, South Africa.

Michael Rademeyer (M)

A2D24, Albury Office Park, 5 Albury Rd., Dunkeld West, Randburg 2196, South Africa.

Tanya van Tonder (T)

Opinion Solutions, Melrose Arch, 44 Melrose Blvd, Birnam, Johannesburg 2196, South Africa.

Sanjida Karim (S)

FIND, Campus Biotech, Chemin des Mines 9, 1202 Geneva, Switzerland.

Rigveda Kadam (R)

FIND, Campus Biotech, Chemin des Mines 9, 1202 Geneva, Switzerland.

Paula Akugizibwe (P)

FIND, Campus Biotech, Chemin des Mines 9, 1202 Geneva, Switzerland.

Classifications MeSH